Travere Therapeutics, Inc. ($TVTX)
Filing Information
| Accession Number | 0001698262-26-000001 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 4, 2026 |
| Document Date | Jan 31, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
86,106
Total Value
$409,100.02
P&L
+inf% (+$2,041,855.20)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Research Officer | Common Stock | โ | Jan 31, 2026 | Grant/Award | 20,090 | $0.00 | $0.00 | 121,533 | Direct | โ | View Details | |
Chief Research Officer | Common Stock | โ | Feb 3, 2026 | Sale | 12,446 | $32.87 | $409,100.02 | 109,087 | Direct | โ | View Details | |
Chief Research Officer | Employee stock option (right to buy) | Derivative | Jan 31, 2026 | Grant/Award | 53,570 | $0.00 | $0.00 | 53,570 | Direct | โ | View Details |